查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1738509

全球医疗微流体设备市场规模（按类型、应用、材料、最终用户、区域范围和预测）

Global Medical Microfluidic Devices Market Size By Type, By Application, By Material, By End-User, By Geographic Scope and Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

医疗微流体设备的市场规模及预测

2024 年医疗微流体设备市场规模价值为 145.8 亿美元，预计到 2032 年将达到 551.9 亿美元，2026 年至 2032 年的复合年增长率为 19.97%。

  • 医疗微流体设备是用于操纵微量流体的小型系统，通常用于诊断、治疗和分析目的。
  • 这些设备广泛应用于照护现场诊断、药物传输、实验室晶片技术等应用。它们能够提供快速、准确且经济高效的测试，从而实现更早的疾病检测和个人化治疗，彻底改变了医疗保健领域。
  • 医疗微流体设备的未来前景光明，精准医疗、穿戴式健康监测和整合生物感测器等领域有望取得进步，以进一步改善患者的治疗效果并简化全球医疗保健流程。

全球医疗微流体设备市场动态

影响全球医疗微流体设备市场的关键市场动态是：

关键市场驱动因素

  • 慢性病盛行率不断上升：糖尿病和癌症等慢性病的发生率不断上升，推动了对先进诊断工具的需求。根据世界卫生组织 (WHO) 的数据，糖尿病影响全球超过 4.22 亿人，因此对照护现场的需求庞大，而微流体设备正是其所擅长的。
  • 政府对医疗创新的支持：各国政府为医疗研究和创新提供奖励和资金。例如，美国国立卫生研究院 (NIH) 已拨款 390 亿美元用于 2023 年的医学研究，以支持用于早期诊断和个人化医疗的微流体设备的研发。
  • 就地检验(POCT) 需求不断增长：POCT 因其能够快速提供准确的检测结果而日益普及。根据美国疾病管制与预防中心 (CDC) 的报告，全球 POCT 市场预计将以每年 10% 的速度成长，这将进一步推动微流体设备的普及。
  • 实验室晶片设备的技术进步：实验室晶片系统的持续技术进步正在扩展其在诊断和药物传输领域的应用。这些创新减少了对笨重实验室设备的需求，并提供了紧凑便携的替代方案，从而推动了市场的成长。

主要问题

  • 复杂的製造流程：微流体装置的製造需要复杂的工程设计，因为需要精确控制流体在微通道中的流动。这种复杂性通常需要使用玻璃和聚合物等特殊材料、软光刻等先进製造技术以及无尘室环境。这些严格的要求增加了製造成本和前置作业时间，限制了製造的可扩展性，并使中小企业难以进入市场。
  • 监管障碍：由于包括微流体在内的医疗设备在诊断和患者照护中发挥至关重要的作用，其监管核准流程尤其艰难。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 实施了严格的测试和认证标准，以确保其安全性和有效性。这些流程耗时耗力，成本高昂，导致创新产品上市延迟，并阻碍了技术应用的步伐。
  • 开发中地区认知度低：儘管微流体设备潜力日益增长，但其应用主要集中在市场。认知度低、医疗基础设施不足以及取得最尖端科技的管道有限，对开发中地区构成了重大挑战。此外，这些地区的医疗保健提供者优先考虑成本效益高的解决方案，这可能会限制对通常被认为昂贵的先进诊断设备的需求。
  • 开发成本高：开发微流体设备需要大量的研究、原型製作和测试，以确保其准确性和可靠性。这需要在技术和熟练的人力方面投入大量的资金。新兴企业和小型企业在获得开发此类设备所需的资金方面可能面临挑战。

主要趋势

  • 与穿戴式健康设备的整合：微流体设备市场的关键趋势是其与穿戴式健康技术的整合。透过将微流体感测器整合到穿戴式装置中，可以追踪各种生理参数，例如血糖浓度、水合状态、电解质平衡等。这种整合能够即时监测患者，尤其是患有糖尿病等慢性疾病的患者，从而增强患者照护，并为早期诊断和预防性医疗保健开闢新的可能性。
  • 个人化医疗：个人化医疗是指根据基因、环境和生活方式等因素为个别患者量身定制治疗方案，它正在推动对微流体设备的需求。这些设备能够快速进行基因和生化分析，为临床医生提供即时数据，指南治疗决策。例如，微流体可用于建立器官晶片系统，模拟患者独特的组织环境，使研究人员能够测试不同药物对特定个体病情的影响。
  • 3D列印在原型製作和製造领域的进展：3D列印技术的运用彻底改变了微流体设备的设计和製造。 3D列印技术能够快速製作复杂微通道设计的原型製作，进而缩短开发功能性设备的时间和降低成本。这一趋势催生了更具创新性的设备配置，使研究人员和製造商能够尝试新的材料和结构，从而提升设备性能。
  • 家庭医疗保健的扩展：远端医疗和家庭医疗保健服务的扩展推动了对易于使用和便携式诊断设备的需求。能够以极少的样本量进行复杂诊断测试的微流体设备正越来越多地被改造以适应家庭使用。这些设备被整合到就地检验套件中，供患者在家中舒适地监测慢性疾病并进行常规健康检查。

目录

第一章 医疗微流体设备全球市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球医疗微流体设备市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球医疗微流体设备市场（按类型）

  • 概述
  • 尖端
  • 感应器
  • 泵浦
  • 阀门
  • 针
  • 搅拌机
  • 反应器
  • 分隔符

6. 全球医疗微流体设备市场（按应用）

  • 概述
  • 诊断设备
  • 治疗设备
  • 研究设备
  • 临床检测设备

7. 全球医疗微流体设备市场（按材料）

  • 概述
  • 玻璃
  • 聚合物
  • 硅
  • 金属
  • 陶瓷製品

第八章全球医疗微流体设备市场（依最终用户）

  • 概述
  • 医院诊所
  • 诊断实验室
  • 製药和生物技术公司
  • 实验室和学术机构

9. 全球医疗微流体设备市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东和非洲

第十章全球医疗微流体设备市场的竞争格局

  • 概述
  • 各公司市场排名
  • 重点发展策略

第十一章 公司简介

  • Abbott Laboratories
  • Agilent Technologies
  • Siemens
  • BIO-RAD Laboratories
  • Raindance Technologies Inc.
  • Micronit Microtechnologies
  • Dolomite Microfluids
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • BioMerieux.

第十二章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十三章 附录

  • 相关调查
简介目录
Product Code: 59336

Medical Microfluidic Devices Market Size and Forecast

Medical Microfluidic Devices Market size was valued at USD 14.58 Billion in 2024 and is projected to reach USD 55.19 Billion by 2032, growing at a CAGR of 19.97% from 2026 to 2032.

  • Medical microfluidic devices are small-scale systems designed to manipulate tiny volumes of fluids, typically for diagnostic, therapeutic, or analytical purposes.
  • These devices are widely used in applications such as point-of-care diagnostics, drug delivery, and lab-on-a-chip technologies. Their ability to provide rapid, accurate, and cost-effective testing has revolutionized healthcare by enabling early disease detection and personalized treatments.
  • The future of medical microfluidics is promising, with advancements expected in areas like precision medicine, wearable health monitoring, and integrated biosensors, further enhancing patient outcomes and streamlining healthcare processes globally.

Global Medical Microfluidic Devices Market Dynamics

The key market dynamics that are shaping the global medical microfluidic devices market include:

Key Market Drivers

  • Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions such as diabetes and cancer are driving demand for advanced diagnostic tools. According to the World Health Organization (WHO), diabetes affects over 422 million people globally, creating a significant need for point-of-care diagnostics, which microfluidic devices excel at delivering.
  • Government Support for Healthcare Innovation: Various governments are providing incentives and funding for healthcare research and innovation. For example, the U.S. National Institutes of Health (NIH) allocated $39 billion in 2023 for medical research, supporting the development of microfluidic devices for early diagnosis and personalized medicine.
  • Increasing Demand for Point-of-Care Testing (POCT): Point-of-care diagnostics, which provide rapid and accurate test results, are becoming more popular due to the convenience they offer. According to a report by the Centers for Disease Control and Prevention (CDC), the global POCT market is expected to grow by 10% annually, further driving the adoption of microfluidic devices.
  • Technological Advancements in Lab-on-a-Chip Devices: Continuous technological advancements in lab-on-a-chip systems have expanded their application in diagnostics and drug delivery. These innovations reduce the need for large laboratory equipment, offering a compact and portable alternative, thus driving market growth.

Key Challenges

  • Complex Manufacturing Processes: The production of microfluidic devices involves intricate engineering, as they require precise control over the fluid flow through microchannels. This complexity often demands the use of specialized materials like glass or polymers, advanced fabrication techniques such as soft lithography, and cleanroom environments. These stringent requirements increase production costs and lead times, limiting the scalability of manufacturing and making it difficult for smaller companies to enter the market.
  • Regulatory Hurdles: Regulatory approval processes are particularly stringent for medical devices, including microfluidics, due to their critical role in diagnostics and patient care. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose rigorous testing and certification standards to ensure safety and efficacy. These processes can be time-consuming and costly, creating delays in bringing innovative products to the market and hindering the pace of technological adoption.
  • Limited Awareness in Developing Regions: Despite the growing potential of microfluidic devices, their adoption is primarily concentrated in developed markets. In developing regions, lack of awareness, inadequate healthcare infrastructure, and limited access to cutting-edge technologies pose significant challenges. Furthermore, healthcare providers in these regions may prioritize cost-effective solutions, limiting the demand for advanced diagnostic devices that can be perceived as expensive.
  • High Development Costs: Developing microfluidic devices involves extensive research, prototyping, and testing to ensure precision and reliability. This requires significant capital investment, both in terms of technology and skilled personnel. Startups and smaller enterprises may face challenges in securing the necessary funding to develop these devices

Key Trends

  • Integration with Wearable Health Devices: A significant trend in the microfluidic devices market is their integration with wearable health technologies. Microfluidic sensors can be embedded in wearable devices to track various physiological parameters, such as glucose levels, hydration status, and electrolyte balance. This integration enables real-time monitoring of patients, particularly those with chronic conditions like diabetes, enhancing patient care and offering new possibilities for early diagnosis and preventative healthcare.
  • Personalized Medicine: Personalized medicine, which tailors' treatments to individual patients based on genetic, environmental, and lifestyle factors, is driving the demand for microfluidic devices. These devices enable rapid genetic and biochemical analyses, providing clinicians with real-time data to guide treatment decisions. For example, microfluidics can be used to create organ-on-a-chip systems that model patient-specific tissue environments, allowing researchers to test how different drugs will affect a particular individual's condition.
  • Advances in 3D Printing for Prototyping and Manufacturing: The use of 3D printing technology has transformed the design and production of microfluidic devices. 3D printing allows for the rapid prototyping of intricate microchannel designs, reducing the time and cost of developing functional devices. This trend is leading to more innovative device configurations, enabling researchers and manufacturers to experiment with new materials and structures that enhance device performance.
  • Expansion of Home Healthcare: The growth of telemedicine and home healthcare services is driving the demand for easy-to-use, portable diagnostic devices. Microfluidic devices, which can perform complex diagnostic tests with minimal sample volumes, are increasingly being adapted for home use. These devices are being integrated into point-of-care testing kits that patients can use to monitor chronic diseases or perform routine health checks from the comfort of their homes.

Global Medical Microfluidic Devices Market Regional Analysis

Here is a more detailed regional analysis of the global medical microfluidic devices market:

North America

  • North America holds the dominant position in the global medical microfluidic devices market, driven by its advanced healthcare infrastructure, strong research and development capabilities, and early adoption of cutting-edge medical technologies. The United States, in particular, plays a significant role due to its substantial investments in biotechnology and healthcare innovation. The region benefits from the presence of key market players and collaborative efforts between industry and academic institutions to develop advanced microfluidic solutions. According to the National Institutes of Health (NIH), U.S. government spending on biomedical research reached $45 billion in 2023, which has accelerated advancements in microfluidic devices.
  • Additionally, North America's regulatory framework is conducive to the rapid commercialization of new medical technologies, further driving market growth. The demand for point-of-care diagnostics, personalized medicine, and minimally invasive procedures is increasing, all of which rely heavily on microfluidic devices. The growing prevalence of chronic diseases, such as diabetes and cardiovascular disorders, is also fueling the adoption of these devices. In 2023, the U.S. Food and Drug Administration (FDA) approved several innovative microfluidic-based diagnostic tools, bolstering market leadership in the region.

Asia Pacific

  • Asia Pacific is the fastest-growing region in the global medical microfluidic devices market, driven by rapid advancements in healthcare infrastructure, increased government investments in biotechnology, and rising demand for affordable, point-of-care diagnostic tools. Countries like China, Japan, and South Korea are leading the charge in adopting microfluidic devices, particularly in diagnostics and drug delivery systems. China's healthcare market is expanding rapidly, and in 2023, the Chinese government announced a $15 billion initiative to boost research in medical technologies, including microfluidics, further accelerating market growth.
  • Additionally, the rising prevalence of chronic diseases and a growing aging population are key factors driving the demand for microfluidic devices in the region. The cost-effectiveness and efficiency of these devices make them appealing in the Asia Pacific market, where access to affordable healthcare solutions is a critical concern. India, too, is emerging as a key player in this sector, with startups and research institutions contributing to the development of low-cost microfluidic diagnostic devices. In 2023, Asia Pacific's microfluidic devices market grew by over 20%, making it the fastest-growing region globally.

Global Medical Microfluidic Devices Market: Segmentation Analysis

The Global Medical Microfluidic Devices Market is segmented on the basis of By Type, By Application, By Material, By End User and By Geography.

Medical Microfluidic Devices Market, By Type

  • Chips
  • Sensors
  • Pumps
  • Valves
  • Needles
  • Mixers
  • Reactors
  • Separators

Based on Type, the Global Medical Microfluidic Devices Market is segmented into Chips, Sensors, Pumps, Valves, Needles, Mixers, Reactors, and Separators. Chips represent the dominant segment due to their widespread use in lab-on-a-chip applications and point-of-care diagnostics. On the other hand, sensors are the fastest-growing segment, driven by the increasing demand for real-time monitoring in wearable health devices and personalized medicine.

Medical Microfluidic Devices Market, By Application

  • Diagnostic Devices
  • Therapeutic Devices
  • Research Devices
  • Clinical Testing Devices

Based on Application, the Global Medical Microfluidic Devices Market is segmented into Diagnostic Devices, Therapeutic Devices, Research Devices, and Clinical Testing Devices. The diagnostic devices segment is the dominant category in the medical microfluidic devices market, primarily driven by the growing demand for point-of-care testing and rapid diagnostic tools for diseases like diabetes, cardiovascular conditions, and infectious diseases. Meanwhile, the therapeutic devices segment is the fastest-growing, fueled by advancements in drug delivery systems and lab-on-a-chip technologies that enable targeted and efficient therapies, particularly for cancer treatment and precision medicine applications.

Medical Microfluidic Devices Market, By Material

  • Glass
  • Polymer
  • Silicon
  • Metals
  • Ceramics

Based on Material, the Global Medical Microfluidic Devices Market is segmented into Glass, Polymer, Silicon, Metals, and Ceramics. Polymer-Based Microfluidic Devices dominate due to their cost-effectiveness, ease of fabrication, and suitability for mass production. Polymers, such as polydimethylsiloxane (PDMS), are widely used because they offer flexibility, biocompatibility, and can be easily molded into intricate designs, making them ideal for disposable diagnostic applications. On the other hand, silicon-based microfluidic devices are the fastest-growing segment. Silicon offers high precision and thermal stability, making it ideal for advanced applications like lab-on-a-chip technologies and drug delivery systems, driving its rapid adoption in high-performance medical devices.

Medical Microfluidic Devices Market, By End-Users

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories & Academic Institutes

Based on End User, the Global Medical Microfluidic Devices Market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Laboratories & Academic Institutes. The hospitals and clinics segment dominates the medical microfluidic devices market, driven by the high demand for point-of-care diagnostics and the increasing need for rapid, accurate testing in clinical settings. However, the diagnostic laboratories segment is the fastest-growing, fueled by the growing adoption of advanced diagnostic tools for disease detection and monitoring.

Medical Microfluidic Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Medical Microfluidic Devices Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America holds the dominant position, driven by its advanced healthcare infrastructure, strong research and development capabilities, and early adoption of cutting-edge medical technologies. Asia Pacific is the fastest-growing region in the global medical microfluidic devices market, driven by rapid advancements in healthcare infrastructure, increased government investments in biotechnology, and rising demand for affordable, point-of-care diagnostic tools.

Key Players

The "Global Medical Microfluidic Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market Abbott Laboratories, Agilent Technologies, Siemens, BIO-RAD Laboratories, Raindance Technologies Inc., Micronit Microtechnologies, Dolomite Microfluids, Thermo Fisher Scientific Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Global Medical Microfluidic Devices Market: Recent Developments
  • In August 2024 Agilent Technologies announced the expansion of its microfluidics manufacturing capabilities by opening a new facility in California. This development aims to meet the rising demand for precision microfluidic devices used in diagnostic applications, ensuring faster production and enhanced product availability.
  • In July 2024 Fluidigm Corporation entered into a strategic collaboration with Thermo Fisher Scientific to integrate microfluidic technology with advanced genomic solutions. The partnership focuses on developing next-generation diagnostic platforms for cancer and infectious diseases, enhancing the capabilities of microfluidic devices in molecular diagnostics.
  • In June 2024 Dolomite Microfluidics launched a new high-throughput droplet generation system aimed at improving drug screening and diagnostics. This system is designed to accelerate research in personalized medicine, offering precise control over droplet size and enhanced throughput for clinical testing applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Chips
  • 5.3 Sensors
  • 5.4 Pumps
  • 5.5 Valves
  • 5.6 Needles
  • 5.7 Mixers
  • 5.8 Reactors
  • 5.9 Separators

6 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Diagnostic Devices
  • 6.3 Therapeutic Devices
  • 6.4 Research Devices
  • 6.5 Clinical Testing Devices

7 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY MATERIAL

  • 7.1 Overview
  • 7.2 Glass
  • 7.3 Polymer
  • 7.4 Silicon
  • 7.5 Metals
  • 7.6 Ceramics

8 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY END-USERS

  • 8.1 Overview
  • 8.2 Hospitals & Clinics
  • 8.3 Diagnostic Laboratories
  • 8.4 Pharmaceutical & Biotechnology Companies
  • 8.5 Research Laboratories & Academic Institutes

9 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East & Africa

10 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Abbott Laboratories
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Agilent Technologies
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Siemens
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 BIO-RAD Laboratories
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Raindance Technologies Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Micronit Microtechnologies
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Dolomite Microfluids
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Thermo Fisher Scientific Inc.
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Illumina Inc.
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 BioMerieux.
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research